カナダの若者の間で口服ニコチン袋の使用が増加: COMPASS-Quebec研究の結果
Katelyn Battista1, Mikael Piché-Ayotte2,3, Slim Haddad2,3,4
1School of Public Health Sciences, University of Waterloo, Waterloo, ON, Canada. kbattist@uwaterloo.ca.
Canadian journal of public health = Revue canadienne de sante publique
|September 2, 2025
まとめ
経口ニコチン袋は キューベック州の若者の間でますます人気があり,タバコに匹敵します. 年齢や他のニコチン製品との併用などの要因が摂取に影響し,リスク感の低下はより高い使用量に関連しています.
科学分野:
- 青少年 の 健康
- ニコチン製品の研究
- 公衆衛生の監視
背景:
- 経口ニコチン袋は 世界的に人気のある 代替ニコチン製品として登場しています
- 青少年の新規ニコチン製品の使用は,関連する危険因子と認識を調査する必要があります.
研究 の 目的:
- ケベック州の若者の間で口服ニコチン袋の使用を調査する.
- ニコチン袋の使用に関連する社会人口統計学的および健康関連のリスク要因を特定する.
- タバコと電子タバコの共同使用パターンと認識されるリスクを探求する.
主な方法:
- ケベック州の高校生13,914人を対象とした調査 (COMPASS研究,2024年).
- 経口ニコチン袋,電子タバコ,タバコの過去1ヶ月の使用を評価する.
- プアソン回帰を用いて相対的なリスクを分析し,各製品のリスク認識を比較した.
主要な成果:
- ニコチンバッグの普及率は (2.6%) 喫煙 (3.0%) と似ており,電子タバコを除く他のニコチン製品に優れていた.
- ニコチンパックの使用のリスクは,高齢の青少年,シスジェンダー少年,ジェンダー多様性のある若者,学問的にリスクの高い学生,および現在のタバコ/電子タバコのユーザーで観察されました.
- ニコチンバッグの依存性 (16%) と健康リスク (ほぼ25%) に関して重大な不確実性が存在し,より高い使用量と相関するより低いリスクが認識されました.
結論:
- 経口ニコチン袋はカナダの若者の間で流行しており,公衆衛生上の懸念を呈しています.
- ニコチンバッグの隠蔽は 電子タバコの普及を促すかもしれません
- これらの新興製品の公衆衛生への影響を軽減するには 適切な規制が不可欠です
さらに関連する動画
関連する概念動画
Stimulants
311
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
311
Drugs Acting on Autonomic Ganglia: Stimulants
1.5K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.5K
Drug Delivery: Enteral Route
709
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
709
Drug Delivery: Miscellaneous Routes
467
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
467
Inhaled Medications
388
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
388


